We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Stakeholders Seek Clarification of FDA’s Adolescent Oncology Patient Guidance
Stakeholders Seek Clarification of FDA’s Adolescent Oncology Patient Guidance
The FDA’s draft guidance on inclusion of adolescents in adult oncology clinical trials should clarify how the agency’s thinking aligns with international regulations, stakeholders said in comments on the June 1 draft.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor